Dr. Saeed Shanehsazzadeh | Agricultural and Biological Sciences | Best Scholar Award
Postdoc at University of New South Wales | Australia
Dr. Saeed Shanehsazzadeh is an accomplished medical physicist with over a decade of international research experience spanning Australia, Singapore, Canada, Belgium, and Iran. He is recognized for his expertise in molecular imaging, radiopharmaceutical development, and nanotechnology. With 55 publications and over 1,564 citations, his scientific influence is evident, reinforced by an H-index of 26. His work centers on imaging modalities like PET, SPECT, MRI, and MPI, developing contrast agents and multimodal probes. Dr. Shanehsazzadeh has received multiple competitive grants and 10 international awards. He is currently a fellow at UNSW and Western Sydney University, driving innovation in Alzheimer’s disease imaging.
Profile:
Orcid | Google Scholar
Education:
Dr. Saeed Shanehsazzadeh earned his PhD in Medical Physics from Tehran University of Medical Sciences, focusing on nanoparticle-based imaging of breast cancer. He holds a Master’s in Medical Physics from Isfahan University, where he investigated radiolabeled GnRH agonists for tumor detection, and a Bachelor’s in Applied Physics from Yazd University. His academic foundation combines theoretical and applied physics, particularly radiological sciences and nanomedicine. Over the years, he has augmented his qualifications with certifications in project management, machine learning, clinical trials, and medical physics training from renowned institutions such as UCLA, Duke University, and ICTP Italy.
Experience:
Dr. Saeed Shanehsazzadeh’s research trajectory includes fellowships at prestigious institutions such as UNSW, University of Western Sydney, and the National University of Singapore. His contributions include developing Alzheimer’s disease nanoprobes, managing imaging labs, and mentoring graduate students. He previously worked as a senior research fellow, lab manager, and assistant professor, managing multidisciplinary projects involving PET, SPECT, and MRI. His postdoctoral appointments in Canada and Belgium furthered his expertise in radiomics and dual-modality contrast agents. He has conducted extensive animal imaging studies, designed SOPs, analyzed quantitative data with Python and MATLAB, and contributed to regulatory and ethical frameworks for biomedical research.
Research Interest:
Dr. Saeed Shanehsazzadeh’s research focuses on molecular imaging, nanomedicine, contrast agent development, and neuroimaging, particularly in Alzheimer’s disease. His interdisciplinary approach integrates physics, chemistry, and biomedical engineering. He is actively investigating dual-modality probes for PET/MRI, MPI tracers, and nanoparticle-based drug delivery systems for brain-targeted therapy. His recent work addresses neuroinflammation, signal detection in multimodal imaging, and the optimization of nanoparticles for theranostics. He is also interested in radiopharmaceutical dosimetry, radiomics, and the application of machine learning in image analysis. His goal is to enhance diagnostic precision and personalized treatment strategies through innovative imaging technologies.
Award and Honors:
Dr. Saeed Shanehsazzadeh has been honored with 10 international awards, reflecting his excellence in research and presentation. Highlights include the Best Poster Award at the 8th ASMI Symposium, Outstanding Lecture Award at the International Isotopes Conference and Best Poster Award at ACRR. He also received awards from IAEA and ICTP for his work on Ga-68 imaging agents and was recognized as the Best Researcher Student at Tehran University. His grants and recognitions span over a dozen competitive travel and research support awards from Australia, Korea, Germany, and Italy, validating the global impact of his work.
Publications:
Title: Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer
Citations: 170
Year of Publication: 2016
Title: Monoclonal antibody conjugated magnetic nanoparticles could target MUC‐1‐positive cells in vitro but not in vivo
Citations: 72
Year of Publications: 2015
Title: Graphene/Cobalt Nanocarrier for Hyperthermia Therapy and MRI Diagnosis
Citations: 71
Year of Publications: 2016
Title: Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process
Citations: 65
Year of Publications: 2016
Title: Dual nano‐sized contrast agents in PET/MRI: a systematic review
Citations: 54
Year of Publications: 2016
Title: Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice
Citations: 53
Year of Publications: 2013
Conclusion:
Dr. Saeed Shanehsazzadeh stands out as a global leader in medical physics and nanotechnology-driven imaging research. His interdisciplinary projects span the most cutting-edge imaging techniques and are backed by strong publication metrics and prestigious awards. His career is marked by sustained innovation, effective collaboration, and mentorship. With continuous funding and institutional trust, his work is shaping the future of personalized medicine and diagnostic radiology. This nomination affirms his enduring impact on molecular imaging and his suitability for recognition as a top researcher in the biomedical imaging domain.